Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein

Journal: Immunity

Published: 2018-07-17

DOI: 10.1016/j.immuni.2018.06.018

Affiliations: 13

Authors: 20

Go to article
Institutions FC
Vanderbilt Vaccine Center (VCC), VU, United States of America (USA) 0.20
Integral Molecular, Inc., United States of America (USA) 0.15
Institute of Human Virology (IHV), UMB, United States of America (USA) 0.10
Department of Pathology, UTMB, United States of America (USA) 0.08
Galveston National Laboratory (GNL), UTMB, United States of America (USA) 0.08
UCLA Department of Epidemiology, United States of America (USA) 0.08
Department of Pathology, Microbiology, and Immunology, VU, United States of America (USA) 0.05
Chemical and Physical Biology Program (CPB), VU, United States of America (USA) 0.05
Department of Cell and Developmental Biology (CDB), VU, United States of America (USA) 0.05
Ragon Institute of MGH, MIT and Harvard, United States of America (USA) 0.05
Department of Integrative Structural and Computational Biology (ISCB), Scripps Research, United States of America (USA) 0.05
Skaggs Institute for Chemical Biology, Scripps Research, United States of America (USA) 0.05
Center for Genetic Medicine Research, Children's National Health System, United States of America (USA) 0.03

Return